Last reviewed · How we verify
Curodont D'senz — Competitive Intelligence Brief
marketed
Self-assembling peptide scaffold
Dentin matrix / hydroxyapatite nucleation
Dentistry / Restorative Medicine
Small molecule
Live · refreshed every 30 min
Target snapshot
Curodont D'senz (Curodont D'senz) — Al-Azhar University. Curodont D'senz is a self-assembling peptide that promotes dentin remineralization and repair by mimicking the natural extracellular matrix structure.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Curodont D'senz TARGET | Curodont D'senz | Al-Azhar University | marketed | Self-assembling peptide scaffold | Dentin matrix / hydroxyapatite nucleation |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Self-assembling peptide scaffold class)
- Al-Azhar University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Curodont D'senz CI watch — RSS
- Curodont D'senz CI watch — Atom
- Curodont D'senz CI watch — JSON
- Curodont D'senz alone — RSS
- Whole Self-assembling peptide scaffold class — RSS
Cite this brief
Drug Landscape (2026). Curodont D'senz — Competitive Intelligence Brief. https://druglandscape.com/ci/curodont-d-senz. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing